Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Anika Therapeutics IncANIK-2.421.431.314.31-43.31%-13.67%0.00$17.71$63.0520,343$15.95

Detail of Anika Therapeutics Inc

 
CEO
Dr. Cheryl Renee Blanchard Ph.D.
Employees
357
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$236M

Company details

Anika Therapeutics Inc. is a prominent player in the healthcare sector, specifically known for its focus on biotechnology and medical devices. The company is dedicated to developing, manufacturing, and commercializing therapeutic products for tissue protection, healing, and repair. It primarily targets musculoskeletal conditions, offering solutions for osteoarthritis pain management through viscosupplementation products. Anika Therapeutics also delves into regenerative medicine, providing products that aid in surgical repair and regenerative tissue growth. By addressing the needs of orthopedic care, Anika Therapeutics impacts both healthcare providers and patients, enhancing quality of life and promoting recovery. With its research and development facilities, the company continuously strives to innovate new treatments to support its mission of improving patient outcomes globally. Anika Therapeutics Inc. plays a crucial role in advancing global healthcare solutions, fostering collaborations and extending its impact across multiple medical disciplines.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$164.17M
Cost of goods (CoG)
-$84.41M
Gross profit (GP)
$79.76M
Operating expense (OE)
-$111.17M
Research and development (R&D)
-$30.39M
General and administrative (G&A)
-$80.78M
Operating income (OI)
-$31.41M
Other income expense (OIE)
-$3.10M
Pretax income (PI)
-$94.53M
Tax (TAX)
-$2.99M
Net income (NI)
-$97.52M
Anika Therapeutics Inc
ANIK • XNGS • US
$15.95
-9.38 (-37.03%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$6.60
Margin profit
-59.40%
52 week low
$14.97
52 week high
$28.75
50-day simple moving average
$17.41
200-day simple moving average
$17.71
Percent held by insiders
3.42%
Percent held by institutions
86.99%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ANIK -37.43%
eps change
ANIK 0.00%